Immunization: Clinical Trials

4 trials of Immunization, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting, 1 withdrawn. 4 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 2, Recruiting 1, Withdrawn 1
Phase 24Completed 2, Recruiting 1, Withdrawn 1

Follow Immunization: new trials by email Literature Review of Immunization trials Research Report on Immunization

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
New Adjuvant Vaccine in Glioblastoma, a Phase 1/2a Study
immunization - Newly Diagnosed Glioblastoma
Phase 1 / Phase 2RecruitingAssistance Publique - Hôpitaux de Paris352024-11-082026-06-11
Immunization With Plasmodium Falciparum Sporozoites Under Chloroquine or Chloroquine/Azithromycin Prophylaxis
Azithromycin capsules, Placebo, Immunization with falciparum - Malaria, Falciparum
Phase 1 / Phase 2WithdrawnRadboud University Medical Center2013-04-012014-11-13
Immunization of Human Volunteers With P. Vivax Irradiated Sporozoites
Immunization with P. vivax irradiated sporozoites - Malaria
Phase 1 / Phase 2CompletedMalaria Vaccine and Drug Development Center272012-06-012018-03-23
Rituximab in the Treatment of Graves' Disease
Methimazole, Rituximab, Immunization with various vaccines - Graves´ Disease, Thyroid Associated Ophthalmopathy
Phase 1 / Phase 2CompletedOdense University Hospital202003-06-012006-10-06

Conditions studied

Malaria (2)  ·  Autoimmune Diseases (1)  ·  Eye Diseases (1)  ·  Glioblastoma (1)  ·  Graves Disease (1)  ·  Graves Ophthalmopathy (1)  ·  Malaria, Falciparum (1)  ·  Thyroid Diseases (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Malaria Vaccine and Drug Development Center (1)  ·  Odense University Hospital (1)  ·  Radboud University Medical Center (1)

Countries

Colombia (1)  ·  Denmark (1)  ·  France (1)  ·  Netherlands (1)

Top investigators

Daniel El-Fassi, MD (1)  ·  LG Visser, MD PhD (1)  ·  RW Sauerwein, MD PhD (1)  ·  Socrates Herrera, MD (1)

Results publications

PMID 19641203, PMID 27760143, PMID 38307966

NIH funding

R01HL086488 (1)